Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer

NCT00768755 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small Cell Lung

Interventions

DRUG: axitinib
DRUG: axitinib
DRUG: chemotherapy
DRUG: axitinib
DRUG: chemotherapy

Sponsor

Pfizer